{
  "ticker": "LLY",
  "target_date": "2025-12-03",
  "actual_date": "2025-12-03",
  "collected_at": "2025-12-08T12:36:46.078845",
  "price": {
    "open": 1046.39,
    "high": 1051.48,
    "low": 1022.32,
    "close": 1033.56005859375,
    "volume": 3447000,
    "change_1d_pct": -1.2,
    "change_7d_pct": -2.47,
    "change_30d_pct": 29.45
  },
  "technicals": {
    "rsi_14": 54.55,
    "sma_20": 1025.03,
    "sma_50": 899.25,
    "macd": 50.224,
    "macd_signal": 57.181,
    "macd_histogram": -6.958,
    "bb_upper": 1133.02,
    "bb_lower": 917.05,
    "price_vs_sma20_pct": 0.83,
    "price_vs_sma50_pct": 14.94,
    "volume_ratio": 0.81
  },
  "fundamentals": {
    "market_cap": 891109376000,
    "pe_ratio": 48.70333,
    "forward_pe": 43.867386,
    "price_to_book": 37.426018,
    "price_to_sales": 14.996842,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.61,
    "pct_from_52w_low": 59.36
  },
  "macro": {
    "spy": {
      "price": 683.89,
      "change_1d_pct": 0.35,
      "change_7d_pct": 2.27
    },
    "vix": {
      "level": 16.08,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.06
    },
    "dollar_index": {
      "level": 98.85
    },
    "gold": {
      "price": 4199.3
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "Walmart Stock Rallies, Pushing Market Cap Above $900 Billion",
      "source": "Yahoo",
      "datetime": 1764799124,
      "summary": "Walmart's market value closed above a $900 billion for the first time on Wednesday. The retailer\u2019s stock rose 1.8%, making it the 12th U.S. company to surpass the milestone, according to Dow Jones Market Data.",
      "url": "https://finnhub.io/api/news?id=eb40673094d3dd4562cdfe52f4f41a2bc39b34be91f39af1fa416f82d4ac32d0"
    },
    {
      "headline": "As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock?",
      "source": "Yahoo",
      "datetime": 1764789262,
      "summary": "Eli Lilly has decided to slash prices of its weight loss drug Zepbound, making it more accessible to customers.",
      "url": "https://finnhub.io/api/news?id=28cda45827c416ae43d0b337a13ec4f83b9f51e8b4bf0214f916b7b1cc7770ff"
    },
    {
      "headline": "1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year",
      "source": "Yahoo",
      "datetime": 1764786600,
      "summary": "A key catalyst may be right around the corner.",
      "url": "https://finnhub.io/api/news?id=13901bd9a393ae2115d256159ad34f2b23845ef2a574c61cdfa98bc737778130"
    },
    {
      "headline": "U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treate",
      "source": "Yahoo",
      "datetime": 1764784740,
      "summary": "Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who",
      "url": "https://finnhub.io/api/news?id=89193a04825a5063668dda8dcb8df9472a8117349940ad675c38aa5ba581f7a5"
    },
    {
      "headline": "Eli Lilly & Co. stock underperforms Wednesday when compared to competitors",
      "source": "MarketWatch",
      "datetime": 1764779460,
      "summary": "Eli Lilly & Co. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a5ae074ecce8b5cc12909b164804ab876e19b61d1910a1a4d0fd3c5f88f50f00"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041104.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"
    },
    {
      "form": "4",
      "date": "2025-11-26",
      "description": "xslF345X05/form4-11262025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/form4-11252025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"
    },
    {
      "form": "4",
      "date": "2025-11-24",
      "description": "xslF345X05/form4-11242025_041101.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"
    },
    {
      "form": "8-K",
      "date": "2025-11-21",
      "description": "lly-20251118.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}